Evidence map›Paper›PMID 25550785›Full record

ArticleInternational journal of clinical and experimental pathology2014

Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth.

Dexia Kong, Lijing Zhao, Yanwei Du, Ping He, Yabin Zou, Luoluo Yang, Liankun Sun, Hebin Wang, Deqi Xu, Xiangwei Meng and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Dexia KongDepartment of Gastroenterology, First Hospital of Jilin University Changchun 130021, China ; Department of Pathophysiology, School of Basic Medicine, Jilin University Changchun 130021, China.
Lijing ZhaoDepartment of Pathophysiology, School of Basic Medicine, Jilin University Changchun 130021, China.
Yanwei DuDepartment of Pathophysiology, School of Basic Medicine, Jilin University Changchun 130021, China.
Ping HeDepartment of Gastroenterology, First Hospital of Jilin University Changchun 130021, China.
Yabin ZouDepartment of Pathology, First Hospital of Jilin University Changchun 130021, China.
Luoluo YangDepartment of Gastroenterology, First Hospital of Jilin University Changchun 130021, China.
Liankun SunDepartment of Pathophysiology, School of Basic Medicine, Jilin University Changchun 130021, China.
Hebin WangDepartment of Pathophysiology, School of Basic Medicine, Jilin University Changchun 130021, China.
Deqi XuNew Vaccine National Engineering Research Center, Beijing Three-Room South Hospital Beijing 100024, China.
Xiangwei MengDepartment of Gastroenterology, First Hospital of Jilin University Changchun 130021, China.
Xun SunDepartment of Pathology, First Hospital of Jilin University Changchun 130021, China.
Jilin University · CNNational Vaccine and Serum Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GRIM-19 has been demonstrated as an important regulator for the normal tissue development. Recently, more evidences regarded GRIM-19 as the new tumor suppressor. However, the possible mechanisms underlying GRIM-19 suppressing cancer growth are unclear. In the present study, Paired hepatocellular carcinoma (HCC) and adjacent non-tumor liver tissues were obtained from 54 patients who underwent primary surgical HCC tissue resection. GRIM-19 protein expression in HCC tissues was performed by immunohistochemistry. Cells were transfected by lentiviruses plasmid expressing GRIM-19. RT-PCR and Western blot analyses were performed to confirm the expression of GRIM-19 mRNA or protein. Cell proliferation was assessed by MTT and FCM analyses. Mitochondrial membrane potential and apoptosis were respectively determined by using fluorescence microscopy and FCM analyses. AKT1, pAKT1, cyclinD1, CDK4, PCNA, Bax, Bcl-2, cleaved caspase-9, cleaved caspase-3, and cytochrome C were detected by Western blot and immunofluorescence. GRIM-19 protein expression was markedly lower in HCC than in paired adjacent non-tumor liver tissues. GRIM-19 overexpression in HCC cells significantly induced cell cycle arrest and enhanced apoptosis. We also found that AKT1 expression and phosphorylation were regulated by the expression of GRIM-19. Collectively, our study demonstrated that GRIM-19 overexpression suppressed HCC growth and downregulated AKT1 expression, suggesting that GRIM-19 might play a crucial role in hepatocarcinogenesis through negatively regulating the PI3K/AKT signaling pathway.

Indexed as

Gene Expression Regulation, NeoplasticSignal TransductionApoptosisApoptosis Regulatory ProteinsCarcinoma, HepatocellularCell Cycle CheckpointsCell Line, TumorCell ProliferationDown-RegulationElectron TransportGene ExpressionHumansLiver NeoplasmsMembrane Potential, MitochondrialMitochondriaNADH, NADPH OxidoreductasesAKT1 protein, humanApoptosis Regulatory ProteinsNADH, NADPH OxidoreductasesNDUFA13 protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTumor Suppressor ProteinsAKT1apoptosiscell cycleGRIM-19hepatocellular carcinoma

Identifiers

PMID25550785
PMCPMC4270598
OpenAlexW138798075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.